Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...